A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to see if ALRT1057 gel is safe and effective in treating Kaposi's sarcoma (KS) when applied to skin .

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Anderson Clinical Research
• Collaborator: Ligand Pharmaceuticals
• Treatments: Alitretinoin

Criteria

Information not available